Vivaldi Capital Management’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$282K	Hold	15,661	–	–	0.04%	233
2025 Q4	$367K	Hold	15,661	–	–	0.05%	194
2025 Q3	$312K	Hold	15,661	–	–	0.04%	215
2025 Q2	$215K	Sell	15,661 -4,463	-22%	-$42.8K	0.03%	273
2025 Q1	$223K	Hold	20,124	–	–	0.04%	247
2024 Q4	$211K	Hold	20,124	–	–	0.03%	260
2024 Q3	$256K	Hold	20,124	–	–	0.07%	178
2024 Q2	$338K	Hold	20,124	–	–	0.1%	155
2024 Q1	$256K	Buy	20,124 +3,663	+22%	+$59.9K	0.07%	182
2023 Q4	$309K	Hold	16,461	–	–	0.09%	162
2023 Q3	$231K	Buy	16,461 +4,961	+43%	+$79.6K	0.08%	168
2023 Q2	$119K	Buy	+11,500	New	+$127K	0.04%	195
2021 Q4	–	Sell	-16,650	Closed	-$280K	–	235
2021 Q3	$280K	Buy	+16,650	New	+$264K	0.06%	185
2020 Q4	–	Sell	-10,000	Closed	-$233K	–	327
2020 Q3	$233K	Sell	10,000 -1,000	-9%	-$22.6K	0.05%	221
2020 Q2	$255K	Buy	+11,000	New	+$269K	0.05%	213